Duncan Bucknell

Welcome to the IP Think Tank podcast for Thursday 13th May 2010.  In this call, Duncan is joined by regular panellist Jeremy Phillips and Peter Ollier to discuss: Pharmaceutical customs seizures...

Duncan Bucknell speaks with Deepak Somaya from the College of Business at Illinois about recent research into economic hostages and exclusive licenses

Oxford University Press doesn’t do things by halves. A beautiful looseleaf they sent over recently for me to review is no exception to this rule.  It’s called ‘Drafting Agreements in the...

He’s busy, but always has time for a chat.  So please do arrange to meet at BIO with Lee Caffin, our head of pharma and biotech. In other news, and because...

Jeremy Phillips and Duncan Bucknell are joined by Darren Olivier and Hal Wegner for an informative and entertaining discussion about the latest patent reform bill in the United States, Bilski, Prometheus...

Do patent settlements help or hurt patients?  What do you think? There’s an interesting post over in the Pharmaceutical IP forum in LinkedIn.  It’s reproduced below with permission from Leighton Howard,...

This case concerns an appeal [2010] EWCA Civ. 33 from the August 2008 judgment in Eli Lilly & Co. v Human Genome Sciences Inc., [2008] EWHC 1903 (Pat), wherein Mr. Justice...

Just don’t read any further unless you’re deep in to pharmaceuticals.   For those who are still reading, every now and then there’s a case or two that we just can’t...

Almost a year to the day after the landmark decision (X ZR 89/07) of the German Federal Court of Justice (Bundesgerichtshof), the UK Court of Appeal has similarly held Lilly’s so-called...

I think what drives our podcasts (and certainly where it began) is our desire to chat with other people in the IP world, and hear what interests them; and to have...